4//SEC Filing
Washburn Theodore James Jr. 4
Accession 0001439222-24-000050
CIK 0001439222other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:15 PM ET
Size
16.8 KB
Accession
0001439222-24-000050
Insider Transaction Report
Form 4
Washburn Theodore James Jr.
Principal Accounting Officer
Transactions
- Exercise/Conversion
Common stock
2024-03-01+777→ 3,663 total - Sale
Common stock
2024-03-05$32.57/sh−295$9,608→ 3,368 total - Exercise/Conversion
Common stock
2024-03-01+2,350→ 5,718 total - Sale
Common stock
2024-03-05$32.57/sh−919$29,932→ 4,799 total - Award
Restricted stock units
2024-03-01+7,350→ 7,350 total→ Common stock (7,350 underlying) - Exercise/Conversion
Restricted stock units
2024-03-01−777→ 777 total→ Common stock (777 underlying) - Exercise/Conversion
Restricted stock units
2024-03-01−2,350→ 4,700 total→ Common stock (2,350 underlying)
Footnotes (7)
- [F1]Includes 752 shares purchased through the Company's employee stock purchase plan.
- [F2]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2022.
- [F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2023.
- [F4]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F5]The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments.
- [F6]The restricted stock units were granted on March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments.
- [F7]The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments.
Documents
Issuer
AGIOS PHARMACEUTICALS, INC.
CIK 0001439222
Entity typeother
Related Parties
1- filerCIK 0001874199
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:15 PM ET
- Size
- 16.8 KB